⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL208605 | 1.00 | — | — | |
| SCHEMBL28146779 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9843064 | 0.98 | SLC7A5 (0.50) | — | |
| Isoleucine SCHEMBL6809072 | 0.79 | PTGS1 (0.61) | — | |
| Isoleucine SCHEMBL10610189 | 0.79 | PTGS1 (0.61) | — | |
| Isoleucine SCHEMBL10610194 | 0.79 | PTGS1 (0.61) | — | |
| Isoleucine SCHEMBL1255582 | 0.77 | SLC7A5 (0.55) | — | |
| Isoleucine SCHEMBL8186739 | 0.77 | SLC7A5 (0.55) | — | |
| Isoleucine SCHEMBL1255583 | 0.77 | SLC7A5 (0.55) | — | |
| Isoleucine SCHEMBL8045737 | 0.77 | SLC7A5 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5476841-A | Inhibitors of herpes viral ribonucleotide reductase | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1995-12-19 | — | — | US | claimed |
| US-20230106131-A1 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF STAPLED PEPTIDES | OHIO STATE INNOVATION FOUNDATION | 2023-04-06 | — | — | US | disclosed |
| US-20230020092-A1 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | ENTRADA THERAPEUTICS, INC. | 2023-01-19 | — | — | US | disclosed |
| WO-2022109058-A1 | NUCLEASES COMPRISING CELL PENETRATING PEPTIDE SEQUENCES | ENTRADA THERAPEUTICS, INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| US-20220033787-A1 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | ENTRADA THERAPEUTICS, INC. | 2022-02-03 | — | — | US | disclosed |
| US-11168310-B2 | Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy | ENTRADA THERAPEUTICS, INC. (US) | 2021-11-09 | — | — | US | disclosed |
| US-20210244824-A1 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | OHIO STATE INNOVATION FOUNDATION | 2021-08-12 | — | — | US | disclosed |
| WO-2021127650-A1 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | ENTRADA THERAPEUTICS, INC. (US) | 2021-06-24 | — | — | WO | disclosed |
| WO-2021041895-A1 | STAPLED BETA-CATENIN LIGANDS | OHIO STATE INNOVATION FOUNDATION (US) | 2021-03-04 | — | — | WO | disclosed |
| US-20200354697-A1 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | 5AM VENTURE MANAGEMENT, LLC | 2020-11-12 | — | — | US | disclosed |
| US-20200276323-A1 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF STAPLED PEPTIDES | OHIO STATE INNOVATION FOUNDATION | 2020-09-03 | — | — | US | disclosed |
| WO-2019165183-A1 | COMPOSITIONS AND METHODS FOR TREATING MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY | ENTRADA THERAPEUTICS, INC. (US) | 2019-08-29 | — | — | WO | disclosed |
| EP-2545033-A2 | PROPIONIC ACIDS, PROPIONIC ACID ESTERS, AND RELATED COMPOUNDS | Promentis Pharmaceuticals, Inc. (US) | 2013-01-16 | — | — | EP | disclosed |
| WO-2011112535-A2 | PROPIONIC ACIDS, PROPIONIC ACID ESTERS, AND RELATED COMPOUNDS | PROMENTIS PHARMACEUTICALS, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| US-4169834-A | RIFAMYCIN DERIVATIVES | GRUPPO LEPETIT S.P.A. (IT) | 1979-10-02 | — | — | US | disclosed |